✦ LIBER ✦

Phase III trial of oral ibandronate versus intravenous zoledronic acid in multiple myeloma: Study design

✍ Scribed by G. Jackson

Book ID: 116319480
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 64 KB
Volume: 38
Category: Article
ISSN: 8756-3282
DOI: 10.1016/j.bone.2006.01.030

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Oral ibandronic acid versus intravenous

Oral ibandronic acid versus intravenous zoledronic acid in treatment of bone metastases from breast cancer: a randomised, open label, non-inferiority phase 3 trial

✍ Barrett-Lee, Peter; Casbard, Angela; Abraham, Jacinta; Hood, Kerenza; Coleman, R 📂 Article 📅 2014 🏛 The Lancet 🌐 English ⚖ 497 KB

408 POSTER Safety comparison of oral iba

408 POSTER Safety comparison of oral ibandronate and intravenous zoledronic acid in metastatic breast cancer patients: Phase III data

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 125 KB

405 POSTER Phase III trial of oral iband

405 POSTER Phase III trial of oral ibandronate and intravenous zoledronic acid in breast cancer patients with bone metastases: comparison of bone turnover markers

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 138 KB

Phase III trial of oral ibandronate and

Phase III trial of oral ibandronate and intravenous zoledronic acid in breast cancer patients with bone metastases: comparative bone turnover marker and safety data

✍ J.-J. Body; Lichinitser; S. Tjulandin; B. Bergström 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 269 KB

Three-year Open Protocol Continuation St

Three-year Open Protocol Continuation Study of Oral Tolerization with Myelin Antigens in Multiple Sclerosis and Design of a Phase III Pivotal Trial

✍ MARIKA J. HOHOL; SAMIA J. KHOURY; SANDRA L. COOK; E. JOHN ORAV; DAVID A. HAFLER; 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 416 KB

Phase III study of PSC-833 (valspodar) i

Phase III study of PSC-833 (valspodar) in combination with vincristine, doxorubicin, and dexamethasone (valspodar/VAD) versus VAD alone in patients with recurring or refractory multiple myeloma (E1A95) : A trial of the Eastern Cooperative Oncology Group

✍ William R. Friedenberg; Montserrat Rue; Emily A. Blood; William S. Dalton; Chaim 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 149 KB 👁 1 views